How the Management of The Trophic Cascade Determines Innovation?
DOI:
https://doi.org/10.31686/ijier.vol7.iss5.1482Keywords:
trophic cascade, innovation, pharma sector, capillarization strategiesAbstract
Large corporations form transnational corporations that, despite working in different countries with specific legal and cultural requirements, have consolidated global management strategies, seeking to operate with maximum efficiency in different economic scenarios. In recent years, there has been a massive proliferation of international companies, most of them located in wealth and industrialized countries, which controll their foreign affiliates. In the current context of globalization, these companies have great influence on the economy, as they interfere with governments and local business relations. Comparing this situation with the multilevel biological trophic pyramid, these companies have a direct and /or indirect impact on other levels, and it equilibrium is directly dependent on the movements taken independently by the different levels. In the competitive marketplace, a large company at the top of the pyramid can change this competitive environment and influence or alter the survival of other trophic levels, due to its economic power and high predatory potential. A more aggressive predator (located at a higher trophic level), despite its low mobility and low innovation capacity, can dominate the environment and extinguish a lower trophic level, with less economic power or less commercial representativeness, which in many cases have excellent innovative capacity. In that case, the whole chain will become unbalanced. The objective of this work is to present a conceptual analysis model to try to scan the corporate chain through the trophic pyramid and its influence on the results, in order to identify improvements and new opportunities for innovation.
References
Formulário Terapêutico Nacional 2010: Rename 2010, Série B. Textos Básicos de Saúde, MINISTÉRIO DA SAÚDE, Secretaria de Ciência, Tecnologia e Insumos Estratégicos Departamento de Assistência Farmacêutica e Insumos Estratégicos Brasília / DF – 2010.
JARDON, Carlos Maria. oct. 2016. Human Capital as Source of Innovativeness in Subsistence Small Businesses. Journal of Technology Management & Innovation, [S.l.], v. 11, n. 3, p. 59-66, ISSN 0718-2724.
MACLEOD, Alistair. Globalization, Markets, and the Ideal of Economic Freedom. Journal of social philosophy [0047-2786] 2005 vol:36 iss:2 pg:143 -158.
SALTMAN, R.B. and FIGUERAS, J. (1997) European Health Care Reform: Analysis of Current Strategies, WHO Regional Publications, European Series No. 72. Copenhagen: WHO Regional Office for Europe.
SALTMAN, Richard B. and BUSSE, Reinhard. Balancing regulation and entrepreneurialism in Europe’s health sector: theory and practice. European Observatory on Health Care Systems Series. Open University Press Buckingham • Philadelphia, 2002.
SIEMS, Thomas F., and RATNER, Adam S. Strengthening globalization's invisible hand: what matters most? Developed financial markets, human capital, access to technology, and strong legal systems are essential for healthy economic growth. Business Economics, vol. 41, no. 4, 2006, p. 16.
SILVA, Ronaldo Ferreira & NASCIMENTO FILHO, Armando P. Estratégias competitivas na indústria farmacêutica brasileira. Uma abordagem sobre as perspectivas e oportunidades da Biotecnologia. XXVII Encontro Nacional de Engenharia de Produção. Foz do Iguaçu, PR, Brasil, 2007.
ZILBER, Silvia NOVAES e DE ARAÚJO, José Braz. Jul. 2012 Small Companies Innovations in Emerging Countries: E-Business Adoption and its Business Model; J.Technol. Manag. Innov. 2012,Volume 7, Issue 2 Santiago.
WOODWARD, David; DRAGER, Nick; BEAGLEHOLE, Robert and LIPSON, Debra. Globalization and health: a framework for analysis and action. Bull World Health Organ [online]. 2001, vol.79, n.9, pp.875-881.
YACH, D, BETTCHER, D. The globalization of public health, I: threats and opportunities. American Journal of Public Health, 1998, 88: 735–738.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Sibylle Hacker, Sylvia Loloma Hacker, Magali T. Uono, Carlos Afonso Casagranda, Marco A. Stephano
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.